Shortest pulmonary vein atrial fibrillation cycle length identifies pulmonary vein isolation responders beyond clinical atrial fibrillation pattern: the FARS-AF II study
EP Europace Journal

Abstract
Atrial fibrillation cycle length (AF-CL) measured in the pulmonary veins (PVs) with a novel simple method [the average of the 10 consecutive Fastest Atrial Repetitive Similar signal interval (FARS10)] accurately identified pulmonary vein isolation (PVI) responders in a preliminary study. This study aims to evaluate differences in PV-FARS10 between paroxysmal and persistent AF and to define the optimal cut-off to predict PVI-only approach success in a large population.
We prospectively enrolled consecutive patients with persistent or paroxysmal AF undergoing first PVI in a single-centre study. The primary endpoint was atrial arrhythmia recurrence. A total of 219 patients (61.8 ± 11.2 years, 25.1% female) were included, with 70 patients (32%) having paroxysmal AF and 149 patients (68%) persistent AF. After a median follow-up of 18.0 [interquartile range (IQR) 10.2–42.3] months, 72 (32.9%) patients experienced AF/atrial flutter (AFL)/atrial tachycardia (AT) recurrence. Patients with shortest PV-FARS10 ≤ 155 ms had a lower rate of AF/AFL/AT recurrence compared to those with shortest PV-FARS10 > 155 ms in the overall population (HR 0.34,
PV-FARS10 can accurately identify PVI responders among patients with persistent and paroxysmal AF. Patients with slow PV (shortest PV-FARS10 > 155 ms) experience a higher rate of AF/AFL/AT recurrence after PVI-only approach. The shortest PV-FARS10 ≤ 155 ms occurs more frequently in paroxysmal AF patients than in persistent AF patients.
Contributors

Francesco Spera
Author

Wim Huybrechts
Author

Hielko Miljoen
Author

Lien Vandaele
Author

Anouk Wittock
Author







